Pathologies and Treatments

The herpes virus family is an important cause of eye infection, known as ocular herpes. Infection by the virus affects almost all ocular tissues, such as the eyelid, conjunctiva, cornea, iris, trabecular meshwork, and retina.

The most frequent manifestations of an ocular infection by the ocular herpes virus are:

  • Blepharoconjunctivitis: involvement of the eyelid and conjunctiva, often combined with palpable preauricular lymph nodes. Vesicles appear on the skin or eyelid margin.
  • Epithelial keratitis: causes foreign body sensation, photophobia, redness, and blurred vision.
  • Stromal keratitis: occurs when the infection affects the deeper layers of the cornea, causing stromal edema, with decreased vision, photophobia, and pain.
  • Iridocyclitis: inflammation of the anterior chamber of the eye, associated with elevated intraocular pressure, causing light sensitivity, blurred vision, pain, and eye redness.

Symptoms

Although it usually manifests in only one eye, some people suffer the infection in both eyes. It typically presents with pain, inflammation, eye redness, tearing, photophobia, and decreased vision. Generally, after the first ocular manifestation, one in four people experiences recurrence in the following years.

The duration of the infection depends on the area affected, each person’s immune response, and proper treatment.

Treatments

Early diagnosis and treatment with antivirals are essential. It is crucial to visit the ophthalmologist for a recommendation of the most appropriate treatment. In cases where significant residual corneal scarring is observed, a corneal transplant may be necessary.

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Dra. Paula Verdaguer,

MD, PhD

Número de Col·legiat COMB: 40737

Ophthalmologist. Specialist in Cornea, Refractive Surgery, and Cataracts

If you found this interesting, feel free to share it here:

Last modified: 19/08/2025
Scroll to Top
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.